FDA clearance for Stealth AXiS™, PMA approval for Infuse™ TLIF, and a strong Q3 earnings beat set the stage for what ...
Medtronic (NYSE: MDT) announced today that it received FDA premarket approval (PMA) for the use of its Infuse bone graft in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results